4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-23-000124
EVP, Quality & Ethics, and CPL acquired 46,155 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Glessner Coleen EVP, Quality & Ethics, and CPL | 2023-06-09 | Grant or award | +15,385 | 134,579 | D: show line 1 in the form | ||
| Glessner Coleen EVP, Quality & Ethics, and CPL | 2023-06-09 | Grant or award | +30,770 | 165,349 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Glessner Coleen EVP, Quality & Ethics, and CPL | 2023-06-09 | Grant or award · Employee Stock Option (Right to buy) | +30,770 | 62,113 | D: show line 3 in the form |
Loading xslF345X04/wk-form4_1686705752.xml…